Cerluten is a Russian bioregulator peptide complex marketed for central nervous system support. Developed by the Khavinson group at the St. Petersburg Institute of Bioregulation and Gerontology, it is derived from young animal brain tissue extracts. It is promoted for cognitive enhancement, neuroprotection, and prevention of age-related neurodegeneration. There is essentially no peer-reviewed clinical evidence meeting international standards, and the bioregulator peptide concept remains outside mainstream Western medicine.
Category: Bioregulator / CNS. Evidence rating: F (anecdotal/unsupported).
Clinical status: No clinical trials registered in international databases. Available as a dietary supplement in Russia.
Cerluten is claimed to contain tissue-specific peptides that interact with DNA in brain cells, regulating gene expression related to neuronal function and repair. The Khavinson theory of bioregulation proposes that short peptides (2-4 amino acids) from specific organs can selectively restore…
Safety considerations: No formal safety assessment by any international regulatory agency; Derived from animal brain tissue, raising concerns about prion and infectious agent contamination; No adverse events data from controlled studies.
Reviewed by the PeptideAtlas Editorial Team.
| Production method | bioactive |
|---|---|
| Anti-doping status | not-listed |
| US regulatory status | Not FDA-approved. Not recognized as a therapeutic or supplement. |
There is no credible scientific evidence that Cerluten has any therapeutic effect. All claims originate from the Khavinson group in Russia and have not been independently replicated or published in internationally recognized peer-reviewed journals.
Unknown. No formal safety studies exist. The fact that it is derived from animal brain tissue raises concerns about prion disease transmission, though the manufacturing process may reduce this risk. There is no way to independently verify safety.
Professor Vladimir Khavinson has proposed that short peptides extracted from specific organs can selectively regulate gene expression in those same organs, restoring youthful function. This theory is not accepted by mainstream Western medicine and has not been validated by rigorous clinical trials.